Meeting Report Volume 12, Issue 24 pp 24484—24503
ARDD 2020: from aging mechanisms to interventions
- 1 Center for Healthy Aging, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark
- 2 Laboratory of Genetics and Genomics, National Institute on Aging Intramural Research Program, National Institutes of Health, Baltimore, MD 21224, USA
- 3 Amazentis SA, EPFL Innovation Park, Bâtiment C, Lausanne, Switzerland
- 4 Center for Glycomics, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark
- 5 Department of Genetics, Albert Einstein College of Medicine, Bronx, NY 10461, USA
- 6 Institute for Aging Research, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA
- 7 Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark
- 8 Institute of Clinical Sciences, Imperial College London, Hammersmith Hospital Campus, London, W12 0NN, UK
- 9 Experimental Gerontology Section, Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA
- 10 Buck Institute for Research on Aging, Novato, CA 94945, USA
- 11 Department of Developmental and Molecular Biology, Institute for Aging Studies, Albert Einstein College of Medicine, Bronx, NY 10461, USA
- 12 European Research Institute for the Biology of Ageing, University Medical Center Groningen, University of Groningen, The Netherlands
- 13 Institute of Translational Medicine, Department of Health Sciences and Technology, Swiss Federal Institute for Technology Zürich, Switzerland
- 14 Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, 1478 Lørenskog, Norway
- 15 School of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton, UK
- 16 Longitudinal Studies Section, Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA
- 17 Calico Life Sciences, LLC, South San Francisco, CA 94080, USA
- 18 Department of Molecular Metabolism, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA
- 19 HautAI OÜ, Tallinn, Estonia
- 20 Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
- 21 Regeneron Pharmaceuticals, Inc. Tarrytown, NY 10591, USA
- 22 Departments of Biology and Medicine, University of Rochester, Rochester, NY 14627, USA
- 23 SENS Research Foundation, Mountain View, CA 94041, USA
- 24 Human Longevity Inc., San Diego, CA 92121, USA
- 25 Department of Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
- 26 DNRF Center for Chromosome Stability, Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
- 27 Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
- 28 Laboratory Genetic Metabolic Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
- 29 Section of Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark
- 30 Gordian Biotechnology, San Francisco, CA 94107, USA
- 31 Blavatnik Institute, Department of Genetics, Paul F. Glenn Center for Biology of Aging Research at Harvard Medical School, Boston, MA 94107, USA
- 32 Molecular Endocrinology Unit, Department of Endocrinology, University Hospital of Odense and University of Southern Denmark, Odense, Denmark
- 33 Department of Molecular Cancer Research, Center for Molecular Medicine, Division of Biomedical Genetics, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
- 34 Departments of Biochemistry and Physiology, Yong Loo Lin School of Medicine, National University Singapore, Singapore
- 35 Centre for Healthy Ageing, National University Healthy System, Singapore
- 36 Department of Genetics and Development, Columbia University Medical Center, New York, NY 10032, USA
- 37 Department of Medicine, University of Wisconsin-Madison and William S. Middleton Memorial Veterans Hospital, Madison, WI 53792, USA
- 38 Sinovation Ventures and Sinovation AI Institute, Beijing, China
- 39 Department of Neuroscience, University of Copenhagen, Denmark
- 40 Deep Longevity Inc., Hong Kong Science and Technology Park, Hong Kong
- 41 Juvenescence Limited, Douglas, Isle of Man, UK
- 42 Institute of Biology of FRC Komi Science Center of Ural Division of RAS, Syktyvkar, Russia
- 43 Institute on the Biology of Aging and Metabolism, Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA
- 44 University of Pittsburgh, Pittsburgh, PA 15260, USA
- 45 Institute of Cellular Biochemistry, University Medical Center Goettingen, Goettingen, Germany
- 46 Department of Neurology and Neurological Sciences and Paul F. Glenn Center for the Biology of Aging, Stanford University School of Medicine, Stanford, CA 94305, USA
- 47 OneSkin Inc., San Francisco, CA 94107, USA
- 48 Department of Biosciences and Nutrition, Karolinska Institute, Stockholm, Sweden
- 49 Department of Biomedical Sciences, University of Padova, Italy
- 50 Institute for Genome Stability in Ageing and Disease, Medical Faculty, University of Cologne, Cologne, Germany
- 51 Department of Pharmacology, School of Medical Sciences, The University of New South Wales, Sydney, NSW, Australia
- 52 Departments of Obstetrics and Gynecology, Genetics and Development, Columbia University, New York, NY 10027, USA
- 53 Division of Cardiovascular Medicine, University of California, San Diego, CA 92093, USA
- 54 Department of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel
- 55 Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark
- 56 Max Planck Institute for Biology of Ageing, Cologne, Germany
- 57 Longevity Vision Fund, New York, NY 10022, USA
- 58 Insilico Medicine, Hong Kong Science and Technology Park, Hong Kong
Received: November 24, 2020 Accepted: December 12, 2020 Published: December 30, 2020
https://doi.org/10.18632/aging.202454How to Cite
Abstract
Aging is emerging as a druggable target with growing interest from academia, industry and investors. New technologies such as artificial intelligence and advanced screening techniques, as well as a strong influence from the industry sector may lead to novel discoveries to treat age-related diseases. The present review summarizes presentations from the 7th Annual Aging Research and Drug Discovery (ARDD) meeting, held online on the 1st to 4th of September 2020. The meeting covered topics related to new methodologies to study aging, knowledge about basic mechanisms of longevity, latest interventional strategies to target the aging process as well as discussions about the impact of aging research on society and economy. More than 2000 participants and 65 speakers joined the meeting and we already look forward to an even larger meeting next year. Please mark your calendars for the 8th ARDD meeting that is scheduled for the 31st of August to 3rd of September, 2021, at Columbia University, USA.